| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/16/2014 | US8911786 Nanoparticle comprising rapamycin and albumin as anticancer agent |
| 12/16/2014 | US8911785 Pharmaceutical compositions comprising N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-OXO-1,2-dihydropyridine-3-carboxamide |
| 12/16/2014 | US8911782 Transdermal patches having ionized beam crosslinked polymers and improved release characteristics |
| 12/16/2014 | US8911781 Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides |
| 12/16/2014 | US8911780 Multiparticulate L-menthol formulations and related methods |
| 12/16/2014 | US8911778 Pellet formulation for the treatment of the intestinal tract |
| 12/16/2014 | US8911777 Pharmaceutical composition of tacrolimus |
| 12/16/2014 | US8911771 Fluid application device and method |
| 12/16/2014 | US8911770 Dissolvable dietary supplement strip and methods for using the same |
| 12/16/2014 | US8911769 Orally disintegrating pharmaceutical composition comprising diclofenac |
| 12/16/2014 | US8911768 Methods for treating retinopathy with extended therapeutic effect |
| 12/16/2014 | US8911767 Hypotensive lipid-containing biodegradable intraocular implants and related methods |
| 12/16/2014 | US8911765 Biodegradable, polymer coverings for breast implants |
| 12/16/2014 | US8911760 Copolymers having polyisobutylene and biodegradable polymer segments |
| 12/16/2014 | US8911757 Pesticidal compositions for insects and arthropods |
| 12/16/2014 | US8911752 Methods of making compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 12/16/2014 | US8911751 Compositions for nasal delivery |
| 12/16/2014 | US8911737 Methods of administering anti-TNFα antibodies |
| 12/16/2014 | US8911736 Combination therapy for treating breast cancer |
| 12/16/2014 | US8911725 Co-targeting of aurora A kinase and LIM kinase 1 for cancer therapy |
| 12/16/2014 | US8911724 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 12/16/2014 | US8911721 Method of constructing gene transport support |
| 12/16/2014 | US8911720 Poly(diol citrate) elastomers |
| 12/16/2014 | US8911719 Tamper resistant dosage forms |
| 12/16/2014 | US8911718 Methods for preparing polymeric reagents |
| 12/16/2014 | US8911713 Method for preventing or treating skin tumor |
| 12/16/2014 | US8911707 Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 12/16/2014 | US8911665 Antiseptic compositions, methods and systems |
| 12/16/2014 | US8911427 Therapeutic agent reservoir delivery system |
| 12/16/2014 | US8911390 Multipart fluid system and a system for regional citrate anticoagulation in an extracorporeal blood circuit |
| 12/11/2014 | US20140364836 Pharmaceutical compositions for the treatment of inner ear disorders |
| 12/11/2014 | US20140364614 Crystalline forms of pitavastatin calcium |
| 12/11/2014 | US20140364595 Conjugate-based antifungal and antibacterial prodrugs |
| 12/11/2014 | US20140364593 Dll3 modulators and methods of use |
| 12/11/2014 | US20140364591 Psca: prostate stem cell antigen and uses thereof |
| 12/11/2014 | US20140364585 Immunoconjugates, compositions for making them, and methods of making and use |
| 12/11/2014 | US20140364513 Highly robust fast-disintegrating tablet and process for manufacturing the same |
| 12/11/2014 | US20140364510 Controlled release aural pressure modulator compositions and methods for the treatment of otic disorders |
| 12/11/2014 | US20140364507 Methods for Identifying Inhibitors of Mannan-binding Lectin-associated Serine Protease (MASP) Proteins and Uses Thereof |
| 12/11/2014 | US20140364505 Lytic agents for use in treating intravascular clots |
| 12/11/2014 | US20140364504 Broad spectrum pharmacological composition for treatmentof various infections and diseases and methodsof use |
| 12/11/2014 | US20140364503 Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
| 12/11/2014 | US20140364501 Compositions of abscisic acid for animal health |
| 12/11/2014 | US20140364499 Coriolus versicolor extracts, methods of isolating biologically-active compounds, and uses thereof |
| 12/11/2014 | US20140364498 Anaplerotic Therapy of Huntington Disease and Other Polyglutamine Diseases |
| 12/11/2014 | US20140364497 Pharmaceutical compositions of fenofibrate |
| 12/11/2014 | US20140364496 Highly penetrating compositions and methods for treating disordered tissues |
| 12/11/2014 | US20140364495 Highly penetrating compositions and methods for treating disordered tissues |
| 12/11/2014 | US20140364494 Processes for making cyclic lipid implants for intraocular use |
| 12/11/2014 | US20140364493 Method of inhibiting remnant lipoprotein production |
| 12/11/2014 | US20140364491 Iron supplement |
| 12/11/2014 | US20140364479 Process for the preparation of glycopyrronium chloride |
| 12/11/2014 | US20140364475 Compositions for the treatment and prevention of eyelid swelling |
| 12/11/2014 | US20140364473 Oral suspension comprising telmisartan |
| 12/11/2014 | US20140364472 Pharmaceutical compositions comprising poh derivatives |
| 12/11/2014 | US20140364471 Pharmaceutical compositions comprising poh derivatives |
| 12/11/2014 | US20140364469 Fungicide Active Substance Combinations |
| 12/11/2014 | US20140364468 Method for treating obesity |
| 12/11/2014 | US20140364463 Nicotinic attenuation of cns inflammation and autoimmunity |
| 12/11/2014 | US20140364461 Method of treating dermatological disorders |
| 12/11/2014 | US20140364460 USE OF FATOSTATIN FOR TREATING CANCER HAVING A p53 MUTATION |
| 12/11/2014 | US20140364459 Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
| 12/11/2014 | US20140364454 Metal-chelating compounds having at least one polyamino chain |
| 12/11/2014 | US20140364453 Salubrinal-driven attenuation of malignant phenotypes of 4t1 breast cancer cells |
| 12/11/2014 | US20140364452 Methods to determine susceptibility to treatment with leukotriene modifiers |
| 12/11/2014 | US20140364450 Aminopyridines useful as inhibitors of protein kinases |
| 12/11/2014 | US20140364447 Dual selective pi3 delta and gamma kinase inhibitors |
| 12/11/2014 | US20140364446 1',4'-thio nucleosides for the treatment of hcv |
| 12/11/2014 | US20140364445 Pharmaceutical composition comprising a trpa1 antagonist and an anticholinergic agent |
| 12/11/2014 | US20140364442 Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds |
| 12/11/2014 | US20140364441 CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF |
| 12/11/2014 | US20140364438 Triazolopyridine derivatives as a tyrosine kinase inhibitor |
| 12/11/2014 | US20140364435 Amino-substituted imidazopyridazines |
| 12/11/2014 | US20140364429 Antiviral compounds highly effective as hcv-ns5a inhibitor |
| 12/11/2014 | US20140364425 Salts of potassium atp channel openers and uses thereof |
| 12/11/2014 | US20140364422 Aqueous Pharmaceutical Composition With Enhanced Stability |
| 12/11/2014 | US20140364420 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists |
| 12/11/2014 | US20140364418 Compositions comprising an aromatic alcohol and a trpv-1 antagonist, and uses thereof |
| 12/11/2014 | US20140364417 Method of treating atrial fibrillation |
| 12/11/2014 | US20140364416 COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE |
| 12/11/2014 | US20140364408 Hydrazide Containing Nuclear Transport Modulators And Uses Thereof |
| 12/11/2014 | US20140364407 Medical or therapeutic application of a composite material of ruthenium with a nitrosyl ligand |
| 12/11/2014 | US20140364406 Method Of Treating Or Preventing Pathologic Effects Of Acute Increases In Hyperglycemia And/Or Acute Increases Of Free Fatty Acid Flux |
| 12/11/2014 | US20140364405 Treatment of seborrhoea |
| 12/11/2014 | US20140364404 Articles and methods of treating vascular conditions |
| 12/11/2014 | US20140364403 Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders |
| 12/11/2014 | US20140364402 Assay for screening compounds that selectively decrease the number of cancer stem cells |
| 12/11/2014 | US20140364401 Antispasmodic 1,2-diols and 1,2,3-triols |
| 12/11/2014 | US20140364400 Esters for treatment of ocular inflammatory conditions |
| 12/11/2014 | US20140364396 Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors |
| 12/11/2014 | US20140364392 Topical aqueous ophthalmic compositions containing a 1h-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease |
| 12/11/2014 | US20140364391 Immobilization Of An Active Agent On A Substrate Using Compounds Including Trihydroxyphenyl Groups |
| 12/11/2014 | US20140364390 Xyloglucan-based compositions for the treatment of gastrointestinal disorders |
| 12/11/2014 | US20140364389 Combination Therapy |
| 12/11/2014 | US20140364388 Method for inducing hepatocyte proliferation and uses thereof |
| 12/11/2014 | US20140364387 Methods and systems for modulating hormones and related methods, agents and compositions |
| 12/11/2014 | US20140364385 Forazolines, compositions thereof and uses thereof |
| 12/11/2014 | US20140364383 Methods and compositions for applying pharmacologic agents to the ear |
| 12/11/2014 | US20140364382 Composition for inhibiting liver function deterioration, containing citrus peel extract or narirutin as active ingredient, and method for extracting narirutin from citrus peel |
| 12/11/2014 | US20140364379 Two part formulation system for ophthalmic delivery |